Activities, Bill Numbers and Titles
|
|
Client: Takeda Pharmaceuticals America, Inc.
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $4,365.48
|
Senate Bill
|
2433
|
An Act relative to step therapy and patient safety
|
Support
|
$0.00
|
N/A
|
House Bill
|
1178
|
An Act relative to promoting transparency in the pharmaceutical industry
|
Neutral
|
$0.00
|
N/A
|
House Bill
|
916
|
An Act relative to co-pay assistance
|
Support
|
$0.00
|
N/A
|
House Bill
|
4134
|
An Act to improve health care by investing in VALUE
|
Oppose
|
$0.00
|
N/A
|
Senate Bill
|
2397
|
Relative to Pharmaceutical Access, Costs and Transparency
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
4228
|
An Act relative to fail first and patient safety
|
Neutral
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
02/06/2020 |
The Rodrigues Committee, Sen. Michael J. Rodrigues
|
State Senate, Chair of Ways and Means Committee (District: First Bristol and Plymouth)
|
$200.00
|
06/10/2020 |
They Cyr Committee, Sen. Julian Cyr
|
State Senate, Assistant Majority Whip (District: Cape and Islands)
|
$200.00
|
| | Total contributions |
$400.00
|
|